March 18 (Reuters) - EVOLVA HOLDING SA EVE.S :
* FULL YEAR REVENUE INCREASED TO CHF 11.6 MILLION IN 2019
(+30%)
MAINLY DRIVEN BY PRODUCT-RELATED REVENUES GROWING BY 59% TO CHF
5.5 MILLION
* FY EBITDA UP 47% COMPARED TO PREVIOUS YEAR (CHF -12.3
MILLION
VERSUS CHF -23.2 MILLION IN 2018)
* FY OPERATING FREE CASH FLOW IMPROVED TO CHF -14.3 MILLION
(+40%)
* MAJOR PROGRESS IN DEVELOPING A NEW PRODUCT, EVE-X157/Z4,
TO BE
LAUNCHED IN LATE 2020
* IN 2020 SEES CONSISTENT PRODUCT RELATED REVENUE GROWTH
ACROSS
BUSINESS SEGMENTS, AND DECLINE IN RESEARCH AND DEVELOPMENT
REVENUE FOLLOWING COMPLETION OF CONTRACT WITH BARDA
* OUTLOOK 2020: EBITDA IS EXPECTED TO REMAIN BROADLY AT
AROUND
PRIOR-YEAR LEVEL
* OUTLOOK 2020: WE ANTICIPATE CASH OUTFLOWS TO BE SLIGHTLY
ABOVE
2019 LEVEL
* OUTLOOK 2020 EXCLUDES ANY IMPACT ON EVOLVA'S BUSINESS FROM
CORONAVIRUS (COVID-19) WHICH CANNOT BE ESTIMATED AT THIS POINT
IN TIME
Source text for Eikon: ID:nTEN0jy67a
Further company coverage: EVE.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))